Ad blocking detected

Thank you for visiting CanadianInsider.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Ultra Club
$500/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads
JOIN THE CLUB

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

OrganiGram Holdings Inc. (T:OGI)

Business Focus: Medical Farming

Dec 03, 2021 04:15 pm ET
S&P Dow Jones Indices Announces Changes to the S&P/TSX Composite Index
TORONTO, Dec. 3, 2021 /CNW/ - As a result of the quarterly review, S&P Dow Jones Indices will make the following changes to the S&P/TSX Composite Index prior to the open of trading on Monday, December 20, 2021:
Nov 23, 2021 06:00 am ET
Organigram Reports Fourth Quarter Fiscal 2021 Results
Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (together, the “Company” or “Organigram”), a leading licensed producer of cannabis, announced its results for the fourth quarter ended August 31, 2021 (“Q4 Fiscal 2021”).
Nov 18, 2021 06:00 am ET
Organigram Launches New Wellness Brand, Monjour
Organigram Holdings Inc. (“Organigram” or the “Company”) (TSX: OGI) (NASDAQ: OGI), the parent company of Organigram Inc., a leading Canadian producer of cannabis, is pleased to announce the launch of Monjour, the Company’s new wellness brand, offering high-quality, CBD-forward products for consumers seeking easy and convenient ways to incorporate cannabidiol (CBD) into their daily wellness routine. Monjour’s first offerings in this emerging category include both vegan-friendly as well as sugar-free soft chews, both in assorted flavours.
Nov 15, 2021 06:00 am ET
Organigram to Report Fourth Quarter and Full Year Fiscal 2021 Results on November 23, 2021
Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (together, the “Company” or “Organigram”), a leading licensed producer of cannabis, announced today it will report earnings results for its fourth quarter and full year fiscal 2021 ended August 31, 2021 on Tuesday, November 23, 2021 before market open.
Nov 01, 2021 06:00 am ET
Organigram Provides Corporate Update
Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI) (the “Company” or “Organigram”), the parent company of Organigram Inc., a leading licensed producer of cannabis, provided a corporate update today.
Aug 31, 2021 05:10 pm ET
Organigram Holdings Inc. Files Final Base Shelf Prospectus
Organigram Holdings Inc. (“Organigram” or the “Corporation”) (TSX: OGI) (NASDAQ: OGI) announced today that it has obtained a receipt for a final short form base shelf prospectus (the “Base Shelf Prospectus”) filed with the securities commissions in each of the provinces and territories of Canada. A corresponding shelf registration statement on Form F-10 (the “Registration Statement”) has been filed with the United States Securities and Exchange Commission (SEC File No. 333-257363), but is not yet effective.
Aug 25, 2021 06:00 am ET
Organigram Extends Popular SHRED Product Portfolio with High-quality, Value-priced SHRED’ems Gummies
Organigram Holdings Inc. (“Organigram” or the “Company”) (TSX: OGI) (NASDAQ: OGI), the parent company of Organigram Inc., a leading Canadian producer of cannabis, is pleased to announce the launch of SHRED’ems, a high-quality and bold flavoured lineup of cannabis-infused gummies. SHRED’ems is an extension of the Company’s highly popular, value-priced SHRED product portfolio which includes SHRED milled flower and SHRED Jar of Joints. Since launch in early August, SHRED’ems has already demonstrated great momentum, capturing the leading market share position of t
Aug 17, 2021 06:00 am ET
Organigram Launches Edison JOLTS, Reinvents the Ingestible Extract
Organigram Holdings Inc. (“Organigram” or the “Company”) (TSX: OGI) (NASDAQ: OGI), the parent company of Organigram Inc., a leading Canadian producer of cannabis, is pleased to announce the launch of Edison Cannabis Co. (“Edison”) JOLTS, Canada’s first flavoured high potency THC lozenge. Edison JOLTS are available in a package of 10 mint flavoured lozenges with 10 mg of THC per lozenge for a total of 100mg per pack.
Aug 04, 2021 06:00 am ET
Organigram Appoints Beena Goldenberg as Chief Executive Officer
Organigram Holdings Inc. (“Organigram” or the “Company”) (TSX: OGI) (NASDAQ: OGI), the parent company of Organigram Inc., a leading Canadian producer of cannabis, is pleased to announce Beena Goldenberg, formerly Chief Executive Officer of The Supreme Cannabis Company Inc. and previously Chief Executive Officer at Hain-Celestial Canada, ULC, has been appointed the Company’s new Chief Executive Officer (CEO). Ms. Goldenberg will assume the role effective September 9, 2021.
Jul 15, 2021 06:00 am ET
Organigram Launches Cannabis Innovators Panel
Organigram Holdings Inc. (“Organigram” or the “Company”) (TSX: OGI) (NASDAQ: OGI), the parent company of Organigram Inc., a leading producer of cannabis, is pleased to announce the launch of the Cannabis Innovators Panel, a cannabis consumer panel offering real-time insights into consumer preferences, usage occasions, and future development opportunities. This online panel will engage with 2,500 participants across Canada on an ongoing basis.
Jul 13, 2021 06:00 am ET
Organigram Reports Third Quarter Fiscal 2021 Results
Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (together, the “Company” or “Organigram”), a leading licensed producer of cannabis, announced its results for the third quarter ended May 31, 2021 (“Q3 2021”).
Jul 05, 2021 06:00 am ET
Organigram to Report Third Quarter Fiscal 2021 Results on July 13, 2021
Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (the “Company” or “Organigram”), a leading licensed producer of cannabis, announced today it will report earnings results for its third quarter Fiscal 2021 ended May 31, 2021 on Tuesday July 13, 2021 before market open.
Jun 24, 2021 05:09 pm ET
Organigram Holdings Inc. Files Preliminary Base Shelf Prospectus
MONCTON, NB, June 24, 2021 /CNW/ - Organigram Holdings Inc. ("Organigram" or the "Corporation") (TSX: OGI) (NASDAQ: OGI) announced today that it has a filed a preliminary short form base shelf prospectus (the "Base Shelf Prospectus") with the securities commissions in each of the provinces and territories of Canada. A corresponding shelf registration statement on Form F-10 (the "Registration Statement") has been filed with the United States Securities and Exchange Commission but is not yet effective. 
Jun 03, 2021 06:42 pm ET
Organigram Recruits for as Many as 75 Roles Based in Moncton, New Brunswick
Organigram Holdings Inc. (“Organigram” or the “Company”) (TSX: OGI) (NASDAQ: OGI), the parent company of Organigram Inc., a leading producer of cannabis, is pleased to announce that it is currently recruiting for as many as 75 positions, across most functional areas of the Company. Positions include those in Operations, Production, Sanitation, Cultivation, Sales, Marketing, Research, and Quality Assurance.
May 31, 2021 06:00 am ET
Organigram Appoints Senior Vice President of Marketing
Organigram Holdings Inc. (“Organigram” or the “Company”) (TSX: OGI) (NASDAQ: OGI), the parent company of Organigram Inc., a leading producer of cannabis, is pleased to announce the appointment of Megan McCrae as the Company’s Senior Vice President of Marketing and Communications. Ms. McCrae will assume her new role effective today.
May 18, 2021 06:00 am ET
Organigram Launches Big Bag o’ Buds Indoor-grown, Strain-specific Dried Flower in 28g Value Format
Organigram Holdings Inc. (“Organigram” or the “Company”) (TSX: OGI) (NASDAQ: OGI), the parent company of Organigram Inc., a leading licensed producer of cannabis, is pleased to announce the launch of Big Bag o’ Buds, a lineup of dried flower products featuring a roster of well-known genetics and an exciting rotation of one-time offerings (OTO) in a 28g format.
May 10, 2021 06:00 am ET
Organigram Appoints Vice President of Innovation
Organigram Holdings Inc. (“Organigram” or the “Company”) (TSX: OGI) (NASDAQ: OGI), the parent company of Organigram Inc., a leading producer of cannabis, is pleased to announce the appointment of Borna Zlamalik as the Company’s Vice President of Innovation. Mr. Zlamalik will assume his new role effective today.
May 03, 2021 06:00 am ET
Organigram CEO Steps Away From Role, Will Continue to Act as a Special Advisor to the Board of Directors; Interim Leadership Appointed
The Board of Directors (the “Board”) of Organigram Holdings Inc. (“Organigram” or the “Company”) (TSX: OGI) (NASDAQ: OGI) has confirmed that Greg Engel is stepping away from his role as CEO effective today, however he will continue to act as a special advisor to the Board through a transition period. The Board is grateful for the contributions Greg has made since joining the Company in 2017.
Apr 22, 2021 01:30 pm ET
Organigram Expands Edison Cannabis Co. Dried Flower Portfolio with Two New High THC Strains: GMO Cookies and MAC-1
As part of the continued expansion of its Edison Cannabis Co. (“Edison”) line of products, Organigram Holdings Inc. (“Organigram” or the “Company”) (TSX: OGI) (NASDAQ: OGI), the parent company of Organigram Inc., a leading producer of cannabis, is pleased to announce the launch of two new Edison dried flower strains including the potent GMO Cookies and legendary citrus diesel MAC-1.
Apr 13, 2021 06:00 am ET
Organigram Reports Second Quarter Fiscal 2021 Results
Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (together, the “Company” or “Organigram”), a leading licensed producer of cannabis, announced its results for the second quarter ended February 28, 2021 (“Q2 2021”).
Apr 06, 2021 06:00 am ET
AgraFlora and Other Owners Agree to Sell Edibles Business for $35 Million to Organigram
AgraFlora Organics International Inc. (“AgraFlora” or the “Company”) (CSE: AGRA) (Frankfurt: PU31) (OTCPK: AGFAF) is pleased to announce that it and its fellow shareholders have entered into an agreement to sell The Edibles & Infusions Corporation...
Apr 06, 2021 06:00 am ET
Organigram Acquires Soft Chew Manufacturer: Edibles & Infusions Corporation, a Cannabis Processor Backed by Decades of Confectionary Experience
Organigram Holdings Inc. (“OGI”, TSX: OGI and NASDAQ: OGI), the parent company of Organigram Inc. (together with OGI, “Organigram” or the “Company”), a leading producer of cannabis, is pleased to announce it has acquired all of the issued and outstanding shares of The Edibles & Infusions Corporation (“EIC”) (the “EIC Acquisition”) for consideration of $22.0 million, plus up to an additional $13.0 million in shares (the “Milestone Consideration”) payable upon the EIC business achieving certain earnout milestones (the “Milestones”). The EIC Acquisition further broadens Organigram’s continuum of
Apr 05, 2021 08:00 pm ET
Organigram to Report Second Quarter Fiscal 2021 Results on April 13, 2021
Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (the “Company” or “Organigram”), a leading licensed producer of cannabis, announced today it will report earnings results for its second quarter Fiscal 2021 ended February 28, 2021 on Tuesday April 13, 2021 before market open.
Apr 01, 2021 09:00 pm ET
Organigram Repays Credit Facilities with Bank of Montreal
Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (collectively, the “Company” or “Organigram”), a leading licensed producer of cannabis, is pleased to announce that the Company has repaid all outstanding balances (approximately $58.5 million) (the “Repayment”) under the facilities provided under its credit agreement (the “Credit Agreement”) dated November 27, 2020, with Bank of Montreal (“BMO”) as lead arranger and agent as well as a syndicate of other lenders.
Mar 30, 2021 06:00 am ET
Organigram Launches “Indi”, an Indica-only Brand, and Three New Edison Indica Pre-rolls: Black Cherry Punch, Ice Cream Cake (I.C.C.) and Slurricane
Building on the Company’s ongoing genetic exploration and product development program, Organigram Holdings Inc. (“Organigram” or the “Company”) (TSX: OGI) (NASDAQ: OGI), the parent company of Organigram Inc., a leading producer of cannabis, is pleased to announce the launch of two new recreational product offerings:
Mar 12, 2021 04:15 pm ET
S&P Dow Jones Indices Announces Changes to the S&P/TSX Composite Index
TORONTO, March 12, 2021 /CNW/ - As a result of the quarterly review, S&P Dow Jones Indices will make the following changes to the S&P/TSX Composite Index prior to the open of trading on Monday, March 22, 2021:
Mar 11, 2021 06:00 am ET
Organigram and BAT Form Product Development Collaboration – Includes Strategic Investment from BAT for 19.9% Equity Interest
Organigram Holdings Inc. (“OGI”, TSX: OGI and NASDAQ: OGI) is pleased to announce a C$221 million strategic investment from a wholly-owned subsidiary of BAT (LSE:BATS and NYSE:BTI). The BAT subsidiary has subscribed for approximately 58.3 million common shares of OGI, which represents a 19.9% equity interest1 on a post-transaction basis for total proceeds of approximately C$221 million (“Investment Proceeds”) at a price per share of C$3.792, based on a five-day volume weighted average price on the TSX ending March 9, 2021.
Mar 02, 2021 06:00 am ET
Organigram Launches SHRED Tropic Thunder Jar of J’s (Jar of Joints) and Trailblazer SNAX Milk Chocolate Bars
As part of its consumer-first product innovation strategy, Organigram Holdings Inc. (“Organigram” or the “Company”) (TSX: OGI) (NASDAQ: OGI), the parent company of Organigram Inc., a leading producer of cannabis, is pleased to announce the launch of two new additions to the Company’s recreational cannabis product portfolio: SHRED Tropic Thunder Jar of Joints and Trailblazer SNAX Milk Chocolate Bars.
Feb 23, 2021 04:00 pm ET
Organigram Holdings Inc. Announces Election of Directors
MONCTON, NB, Feb. 23, 2021 /CNW/ - Organigram Holdings Inc. ("Organigram" or the "Corporation") (TSX: OGI) (NASDAQ: OGI) announced today the results of voting at its annual meeting of shareholders held on February 23, 2021 (the "Meeting").
Feb 12, 2021 09:17 am ET
IIROC Trade Resumption - OGI
TORONTO, Feb. 12, 2021 /CNW/ - Trading resumes in:
Feb 12, 2021 09:13 am ET
IIROC Trading Halt - OGI
TORONTO, Feb. 12, 2021 /CNW/ - The following issues have been halted by IIROC:
Feb 11, 2021 09:06 am ET
IIROC Trade Resumption - OGI
TORONTO, Feb. 11, 2021 /CNW/ - Trading resumes in:
Feb 11, 2021 09:03 am ET
IIROC Trading Halt - OGI
TORONTO, Feb. 11, 2021 /CNW/ - The following issues have been halted by IIROC:
Feb 11, 2021 08:59 am ET
IIROC Trade Resumption - OGI
TORONTO, Feb. 11, 2021 /CNW/ - Trading resumes in:
Feb 11, 2021 08:52 am ET
IIROC Trading Halt - OGI
TORONTO, Feb. 11, 2021 /CNW/ - The following issues have been halted by IIROC:
Feb 10, 2021 10:49 am ET
IIROC Trade Resumption - OGI
TORONTO, Feb. 10, 2021 /CNW/ - Trading resumes in:
Feb 10, 2021 10:36 am ET
IIROC Trading Halt - OGI
TORONTO, Feb. 10, 2021 /CNW/ - The following issues have been halted by IIROC:
Feb 09, 2021 10:09 am ET
IIROC Trade Resumption - OGI
TORONTO, Feb. 9, 2021 /CNW/ - Trading resumes in:
Feb 09, 2021 10:02 am ET
IIROC Trading Halt - OGI
TORONTO, Feb. 9, 2021 /CNW/ - The following issues have been halted by IIROC:
Feb 02, 2021 09:00 am ET
Organigram Announces Executive Changes
Organigram Holdings Inc. (“Organigram” or the “Company”) (TSX: OGI) (NASDAQ: OGI) announces Matt Rogers, Senior Vice President, Operations, will be leaving Organigram at the end of May 2021 to pursue other interests.
Jan 12, 2021 06:00 am ET
Organigram Reports First Quarter Fiscal 2021 Results
Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (together, the “Company” or “Organigram”), a leading licensed producer of cannabis, announced its results for the first quarter ended November 30, 2020 (“Q1 Fiscal 2021” or “Q1 2021”).
Jan 11, 2021 06:00 am ET
Organigram Appoints Marni Wieshofer to the Board of Directors
Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (the “Company” or “Organigram”), a leading licensed producer of cannabis, is pleased to announce the appointment of Marni Wieshofer, to the Company’s Board of Directors. Ms. Wieshofer is Organigram’s first U.S. domiciled director and will assume her board position effective January 12, 2021.
Jan 04, 2021 06:00 am ET
Organigram to Report First Quarter Fiscal 2021 Results on January 12, 2021
Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (the “Company” or “Organigram”), a leading licensed producer of cannabis, announced today it will report earnings results for its first quarter Fiscal 2021 ended November 30, 2020 on Tuesday January 12, 2021 before market open.
Dec 22, 2020 06:00 am ET
Organigram Expands Edison Portfolio With Three New Indica Genetics – Black Cherry Punch, Ice Cream Cake (I.C.C.), and Slurricane
Organigram Holdings Inc. (NASDAQ:OGI) (TSX:OGI), the parent company of Organigram Inc. (the “Company” or “Organigram”), a leading licensed producer of cannabis, is pleased to announce the launch of three new Edison Cannabis Co. (“Edison”) Indica strains including high potency Black Cherry Punch and Ice Cream Cake (I.C.C.) and full flavour Slurricane.
Dec 16, 2020 06:00 am ET
Organigram Launches New 1g Trailblazer Torch Vape Cartridges
Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (the “Company” or “Organigram”), a leading licensed producer of cannabis, is pleased to announce the launch of Trailblazer Spark, Flicker and Glow 510-thread Torch vape cartridges in a new 1g format.
Nov 30, 2020 06:00 am ET
Organigram Reports Fourth Quarter 2020 Results
Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (together, the “Company” or “Organigram”), a leading licensed producer of cannabis, announced its results for the fourth quarter ended August 31, 2020 (“Q4” or “Q4 2020”).
Nov 24, 2020 05:20 pm ET
Organigram to Report Fourth Quarter and Full Year Fiscal 2020 Results on November 30, 2020
Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (the “Company” or “Organigram”), a leading licensed producer of cannabis, announced today it will report earnings results for its fourth quarter and full year Fiscal 2020 ended August 31, 2020 on Monday November 30th, 2020 before market open.
Nov 17, 2020 06:00 am ET
Organigram Launches Edison RE:MIX Rapid Dissolvable Cannabis Powder
Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (the “Company” or “Organigram”), a leading licensed producer of cannabis, is pleased to announce the launch of Edison RE:MIX dissolvable cannabis powder. RE:MIX is the latest innovation from the Company’s Edison brand portfolio of products, offering Canadian adults the opportunity to enjoy cannabis their way.
Nov 12, 2020 09:13 am ET
Organigram Closes Previously Announced Underwritten Public Offering
Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (the “Company” or “Organigram”), a leading licensed producer of cannabis, announced today the closing of its previously announced underwritten public offering of units of the Company (the “Units”) for total gross proceeds of C$69,143,750 (the “Offering”). The Company sold 37,375,000 Units at a price of C$1.85 per Unit, including 4,875,000 Units sold pursuant to the exercise in full of the underwriters’ over-allotment option.
Nov 10, 2020 06:09 am ET
Organigram Announces $60 Million Underwritten Public Offering
MONCTON, NB, Nov. 10, 2020 /CNW/ - Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (the "Company" or "Organigram"), a leading licensed producer of cannabis, announced today an underwritten public offering of units of the Company (the "Units") whereby a syndicate of underwriters, led by Canaccord Genuity Corp., has agreed to purchase 32,500,000 Units from the Company at a price of C$1.85 per Unit, for total gross proceeds of C$60,125,000 (the "Offering").
Nov 10, 2020 06:09 am ET
Organigram Announces $60 Million Underwritten Public Offering
MONCTON, NB, Nov. 10, 2020 /PRNewswire/ - Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (the "Company" or "Organigram"), a leading licensed producer of cannabis, announced today an underwritten public offering of units of the Company (the "Units") whereby a syndicate of underwriters, led by Canaccord Genuity Corp., has agreed to purchase 32,500,000 Units from the Company at a price of C$1.85 per Unit, for total gross proceeds of C$60,125,000 (the "Offering").
Nov 09, 2020 06:00 am ET
Organigram Launches Trailblazer Kushmas Stix and Edison Bytes Gingerbread Truffles -- Two New Limited-Edition Holiday Offerings
As winter and the holidays draw nearer, Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (the “Company” or “Organigram”), a leading licensed producer of cannabis, is pleased to announce the launch of the Company’s limited-edition spirit-of-the-season offerings, Trailblazer Kushmas Stix and Edison Bytes Gingerbread Truffles.
Oct 30, 2020 06:00 am ET
Organigram CEO Joins Canadian Chamber of Commerce Board of Directors
Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (the “Company” or “Organigram”), a leading licensed producer of cannabis, is pleased to announce that the Company’s Chief Executive Officer, Greg Engel, has accepted a position on the Board of Directors of the Canadian Chamber of Commerce.
Oct 23, 2020 06:00 am ET
Organigram Confirms Additional $2.5 Million Investment in Hyasynth Biologicals Inc. as Biosynthesis Pioneer Completes First Milestone Linked to First Sale of Commercial Product and Announces Executive
As an early investor in biosynthesis, Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (the “Company” or “Organigram”), a leading licensed producer of cannabis, is pleased to announce it has funded an additional $2.5 million investment in Hyasynth Biologicals Inc. (“Hyasynth”), a private biotechnology company and pioneer in the field of cannabinoid science and biosynthesis. The announcement comes as Hyasynth makes the first sale of CBDa1 produced and extracted from yeast.
Sep 17, 2020 06:00 am ET
Organigram Expands Strong Value Portfolio With Launch of SHRED: High Quality, High Potency, Affordable Pre-shredded Dried Flower
In an effort to continue to break down the barriers to purchasing from the legal cannabis market in Canada, and reinforce its ongoing commitment to value, Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (the “Company” or “Organigram”), a leading licensed producer of cannabis, is pleased to announce the launch of SHRED, a high quality, high potency, affordable dried flower product pre-shredded for additional consumer convenience.
Aug 18, 2020 06:00 am ET
Organigram Joins Medical Cannabis by Shoppers Inc. and TruTrace in Effort to Track Source and Genetics of Cannabis Used by Medical Patients
Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (the “Company” or “Organigram”), a leading licensed producer of cannabis, is pleased to announce it has partnered with Medical Cannabis by Shoppers™ (“Shoppers”) on Phase 2 of Shoppers’ Pilot Program powered by software partner TruTrace Technologies Inc. (CSE: TTT; OTCQB: TTTSF) (“TruTrace”).
Aug 14, 2020 06:00 am ET
Organigram Sends First Shipment of Indoor-Grown Dried Flower to Israeli Cannabis Producer, Canndoc Ltd.
Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (the “Company” or “Organigram”), a leading licensed producer of cannabis, today announced that it has sent its first shipment of bulk dried flower to Canndoc Ltd. (“Canndoc”), one of Israel’s largest and most established medical cannabis producers, and a subsidiary of InterCure Ltd. (TASE: INCR). The shipment is part of Organigram’s multi-year deal with Canndoc and is estimated to be worth approximately $2.4M CDN.
Aug 04, 2020 06:00 am ET
Organigram Strengthens Edison Flower Portfolio with Three New High Potency Strains – The General (Grapefruit GG4), Chemdog and Samurai Spy (Ninja Fruit)
Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (the “Company” or “Organigram”), a leading licensed producer of cannabis, is pleased to announce the launch of three new strains of Edison Cannabis Co. (“Edison”) dried flower products, including higher tetrahydrocannabinol (THC) options The General (Grapefruit GG4), Chemdog and limited time option Samurai Spy (Ninja Fruit).
Jul 28, 2020 06:00 am ET
Organigram Launches Trailblazer Snax, the Largest, Competitively Priced Cannabis-Infused Chocolate Bar in Canada
Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (the “Company” or “Organigram”), a leading licensed producer of cannabis, is pleased to announce the launch of its most recent cannabis 2.0 product Trailblazer Snax, a premium-quality, value-priced, cannabis-infused chocolate bar.
Jul 21, 2020 06:00 am ET
Organigram Reports Third Quarter Fiscal 2020 Results
Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (together, the “Company” or “Organigram”), a leading licensed producer of cannabis, is pleased to announce its results for the third quarter ended May 31, 2020 (“Q3” or “Q3 2020”).
Jul 20, 2020 07:00 pm ET
Organigram Announces Executive Change
Organigram Holdings Inc. (“Organigram” or the “Company”) (TSX: OGI) (NASDAQ: OGI) announces that Ray Gracewood, Senior Vice President of Marketing and Communications has left Organigram to pursue other interests.
Jul 03, 2020 08:00 am ET
Organigram Provides Update on COVID-19 Corporate Action Plan and Timing for Q3 Results
Organigram Holdings Inc. (“Organigram” or the “Company”) (TSX: OGI) (NASDAQ: OGI) provides a corporate update on recent developments of the Company in relation to the worldwide COVID-19 pandemic and the continuing evolution of the Canadian cannabis industry.
Jun 23, 2020 06:00 am ET
Organigram Holdings Inc. Provides Corporate Updates
Organigram Holdings Inc. (“Organigram” or the “Corporation”) (TSX: OGI) (NASDAQ: OGI) announces a number of corporate updates.
Jun 09, 2020 08:45 am ET
Organigram and Canndoc Sign International Strategic Agreement
Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (the “Company” or “Organigram”), a leading licensed producer of cannabis, today announced that it has entered into a multi-year agreement for supply of dried flower to one of Israel’s largest and most established medical cannabis producers, Canndoc Ltd. (“Canndoc”), a subsidiary of InterCure Ltd. (TASE: INCR/INCR.TA).
May 29, 2020 06:00 am ET
Organigram Successfully Completes Amendment to Credit Facilities with Bank of Montreal
Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (collectively, the “Company” or “Organigram”), a leading licensed producer of cannabis, is pleased to announce that the Company has amended its credit agreement dated May 31, 2019, with Bank of Montreal (“BMO”) as lead arranger and agent as well as a syndicate including three other lenders (the “Credit Agreement Amendment”). The Credit Agreement Amendment modifies certain terms of the $115 million term loan (the “Term Loan”) and $25 million revolving credit facility (the “Revolver”, and together with the T
May 28, 2020 10:48 am ET
Organigram Rolls out Cannabis 2.0 Products to Medical Consumers
Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (the “Company” or “Organigram”), a leading licensed producer of cannabis, is pleased to announce that as of May 19th, 2020, the Company has extended its medical cannabis offering to include products from its cannabis 2.0 adult-use recreational portfolio.
May 14, 2020 06:00 am ET
Organigram announces first phase of return-to-work strategy
As it continues to monitor and assess the implications of the COVID-19 pandemic, Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (the “Company” or “Organigram”), a leading licensed producer of cannabis, has announced the first phase of its return-to-work strategy. The Company has begun to implement a staggered return-to-work plan effective May 13, 2020.
Apr 30, 2020 11:12 am ET
Court Significantly Reduces Scope of Class Action
The Nova Scotia Court of Appeal has partially overturned the certification of a class action (the “Class Action”) against Organigram Inc. (the "Company" or "Organigram") and its parent company Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), a leading licensed producer of cannabis in Canada, on April 30, 2020 thereby significantly reducing the scope of the claim against the Company.
Apr 23, 2020 06:00 am ET
Consumer Research Drives Enhancements to Organigram Adult Recreational Commercial Portfolio
Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (the “Company” or “Organigram”), a leading licensed producer of cannabis, is pleased to provide an update related to the Company’s current and anticipated releases of new adult use recreational cannabis products.
Apr 22, 2020 08:00 am ET
Organigram Holdings Inc. Announces At-The-Market Equity Program
Organigram Holdings Inc. (“Organigram” or the “Corporation”) (TSX:OGI) (NASDAQ:OGI) announced today that it has established an at-the-market equity program (the “ATM Program”) that allows the Corporation to issue up to C$49,000,000 (or its U.S. dollar equivalent) of common shares (“Common Shares”) from treasury to the public from time to time, at the Corporation’s discretion. Any Common Shares sold in the ATM Program will be sold through the Toronto Stock Exchange (the “TSX”), the NASDAQ Global Select Market (the “NASDAQ”) or any other marketplace on w
Apr 14, 2020 06:00 am ET
Organigram Reports Second Quarter Fiscal 2020 Results
Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (together, the “Company” or “Organigram”), a leading licensed producer of cannabis, is pleased to announce its results for the second quarter ended February 29, 2020 (“Q2” or “Q2 2020”).
Apr 06, 2020 07:30 pm ET
Organigram Provides Update on Corporate Action Plan in Response to COVID-19 Pandemic
Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (the “Company” or “Organigram”), a leading licensed producer of cannabis, today announced the temporary layoff of approximately 45 per cent of its workforce primarily to help boost COVID-19 containment efforts representing approximately 400 employees.
Mar 23, 2020 06:00 am ET
Organigram Receives Health Canada License Renewal and Expansion for Final Elements of Phase 5 and Provides COVID-19 Update
Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (the “Company” or “Organigram”), a leading licensed producer of cannabis, is pleased to announce that the Company has received Health Canada’s approval for the licensing of the remainder of its Phase 5 expansion together with the renewal of its licenses for standard cultivation, standard processing and sale for medical purposes under the Cannabis Regulations. The renewed and expanded licenses are effective as of March 20, 2020.
Mar 10, 2020 06:00 am ET
Ideal Potency of Edible Products 5MGs of THC or Less, Organigram Consumer Research Survey Concludes
Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (the “Company” or “Organigram”), a leading licensed producer of cannabis, has released summary findings gathered in a research project designed to learn more about Canadians’ perceptions and attitudes around cannabis edible products.
Mar 04, 2020 06:00 am ET
Organigram Expands Leadership Team with the Appointment of Chief Strategy Officer and Newly Appointed Chief Financial Officer
Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (the “Company” or “Organigram”), a leading licensed producer of cannabis, is pleased to announce that effective today Paolo De Luca, the Company’s current Chief Financial Officer (“CFO”) has been appointed Chief Strategy Officer and Derrick West, currently on the Company’s Board of Directors, is joining the Company as its CFO.
Feb 25, 2020 06:30 pm ET
Organigram Holdings Inc. Announces Election of Directors
Organigram Holdings Inc. (“Organigram” or the “Corporation”) (TSX: OGI) (NASDAQ: OGI) announced today that each of the eight nominees listed in its management information circular dated January 23, 2020 (the “Circular”) was elected as a director of Organigram at the Annual and Special Meeting of Shareholders (the “Meeting”) held on February 25, 2020. The vote was conducted by a show of hands. Detailed results of the votes cast by proxy are set out below:
Feb 20, 2020 07:00 am ET
Organigram Continues Cannabis 2.0 Roll Out, Releases Edison Vape Pens Powered by Feather, and Edison Bytes to Markets Across Canada
Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (the “Company” or “Organigram”), a leading licensed producer of cannabis, is pleased to continue the roll out of its innovative portfolio of recreational adult use cannabis products including vape pens and cannabis-infused chocolate.
Jan 23, 2020 06:00 am ET
Edison La Strada Selected Favourite THC Flower in Canada
Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (the “Company” or “Organigram”), a leading licensed producer of cannabis, is pleased to announce products from its premium adult recreational Edison Cannabis Co. brand have been awarded top honours in the consumer-driven Leafly Readers Choice Awards.
Jan 16, 2020 06:00 am ET
Organigram Secures Supply Agreement With Medical Cannabis by Shoppers
Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (the “Company” or “Organigram”), a leading licensed producer of cannabis, is pleased to announce it has secured a supply agreement with Medical Cannabis by Shoppers, the online medical cannabis platform by Shoppers Drug Mart Inc. (“Shoppers”).
Jan 14, 2020 04:00 pm ET
Organigram Reports First Quarter Fiscal 2020 Results  
Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (the “Company” or “Organigram”), a leading licensed producer of cannabis, is pleased to announce its results for the first quarter ended November 30, 2019 (“Q1” or “Q1 2020”).
Jan 09, 2020 06:00 pm ET
Organigram Selected by Canada’s Top 100 Employers
Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (the “Company” or “Organigram”), a leading licensed producer of cannabis, is pleased to announce it has been chosen as one of Atlantic Canada’s Top Employers.
Jan 03, 2020 07:00 pm ET
Organigram to Report First Quarter Fiscal 2020 Results on January 14th, 2020 and Operational Update
Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (the “Company” or “Organigram”), a leading licensed producer of cannabis, announced today it will report earnings results for its first quarter fiscal 2020 ended November 30, 2019 on Tuesday, January 14th after market close.
Dec 23, 2019 06:00 am ET
Organigram Trailblazer Torch Vape Cartridges Among First ‘Cannabis 2.0’ Products Company Distributes to Market
Organigram Holdings Inc. (NASDAQ:OGI) (TSX:OGI), the parent company of Organigram Inc. (the “Company” or “Organigram”), a leading licensed producer of cannabis, is pleased to announce the first of its ‘Cannabis 2.0’ products have been released, including Trailblazer Spark, Flicker and Glow 510-thread Torch vape cartridges.
Dec 13, 2019 06:00 am ET
Organigram Receives Licensing for Chocolate Production and Packaging Area; Increased Production, Drying and Other Post-Harvesting Areas
Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (the “Company” or “Organigram”), a leading licensed producer of cannabis, is pleased to announce that the Company has received Health Canada’s approval for the licensing of 16 additional cultivation rooms under the Cannabis Regulations. The expanded license was effective as of December 12, 2019.
Dec 04, 2019 08:50 am ET
Organigram Holdings Inc. Announces At-The-Market Equity Program
Organigram Holdings Inc. (“Organigram” or the “Corporation”) (TSX: OGI) (NASDAQ: OGI) announced today that it has established an at-the-market equity program (the “ATM Program”) that allows the Corporation to issue up to C$55,000,000 (or its U.S. dollar equivalent) of common shares (“Common Shares”) from treasury to the public from time to time, at the Corporation’s discretion. Any Common Shares sold in the ATM Program will be sold through the Toronto Stock Exchange (the “TSX”), the NASDAQ Global Select Market (the “NASDAQ”) or any other marketplace on
Nov 25, 2019 06:00 am ET
Organigram Reports Fourth Quarter and 2019 Fiscal Year Results
Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (the “Company” or “Organigram”), a leading licensed producer of cannabis, is pleased to announce its results for the fourth quarter and fiscal year ended August 31, 2019 (“Q4” or “Q4 2019”).
Nov 11, 2019 06:30 pm ET
Organigram Provides Corporate Update
Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (the “Company” or “Organigram”), a leading licensed producer of cannabis, provided a corporate update today and announced details for its fiscal fourth quarter ended August 31, 2019 (“Q4 2019”) and full year 2019 conference call. The Company is scheduled to report its fourth quarter and full year earnings results for its fiscal year ended August 31, 2019 on Monday, November 25, 2019 before market open.
Nov 11, 2019 06:00 am ET
Organigram Wins Top Product Award in High THC Bottled Oil Category at 2019 Canadian Cannabis Awards
Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (the “Company” or “Organigram”), a leading licensed producer of cannabis, is pleased to announce that the Company was honoured on November 8 at the Canadian Cannabis Awards Gala in Toronto with the Top Product Award in the High THC Bottled Oil Category for its medical product, Rossignol. The annual ceremony honours outstanding people, products and companies in Canadian cannabis.
Nov 08, 2019 08:24 am ET
RAMM Pharma Corp. Commences Trading on the Canadian Securities Exchange Under Ticker Symbol “RAMM” and Provides Corporate Update
RAMM Pharma Corp. (including its wholly owned subsidiaries, the “Company” or "RAMM") (CSE: RAMM), a leader in plant-derived cannabinoid pharmaceutical products, is pleased to announce that trading in its common shares on the Canadian Securities...
Nov 07, 2019 06:00 am ET
A Strong Step Forward for the Legal Cannabis Market in Ontario
Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (the “Company” or “Organigram”), a leading licensed producer of cannabis is pleased to offer its support for the Ontario provincial government’s planned improvements to that province’s retail cannabis program announced yesterday.
Oct 10, 2019 06:00 am ET
Organigram Awarded Excellence in Manufacturing Consortium Award
Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (the “Company” or “Organigram”), a leading licensed producer of cannabis, is pleased to announce that the Company was recognized at the Excellence in Manufacturing Consortium (“EMC”) Awards of Excellence ceremony in Toronto on October 9.
Oct 07, 2019 06:00 am ET
Organigram Assumes Board Positions on International Cannabis Industry Advocacy Organizations
Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (the “Company” or “Organigram”), a leading licensed producer of cannabis, is pleased to announce that a representative of the Company has assumed board positions with three international organizations committed to promote and foster global cannabis industry growth: The American Trade Association for Cannabis and Hemp, The Policy Center for Public Health & Safety (both U.S.-based) and the European Alliance for Medical Cannabis.
Oct 03, 2019 08:30 am ET
Organigram Holdings Inc. CEO Discusses Rampant Growth in Exclusive NetworkNewsWire Broadcast
via NetworkNewsAudio – Organigram Holdings Inc. (TSX: OGI) (NASDAQ: OGI), parent company of Organigram Inc., today announces the broadcast of its audio interview with NetworkNewsAudio (NNA), a NetworkNewsWire (NNW) solution that delivers clients...
Sep 26, 2019 06:00 am ET
BTV Uncovers Companies in the Growing Cannabis Sector
Vancouver, British Columbia--(Newsfile Corp. - September 26, 2019) - On national TV Sat. Sept. 28 & Sun. Sept. 29, 2019 - As the Canadian cannabis sector remains strong, BTV- Business Television visits thriving opportunities ripe for investment.
Sep 09, 2019 09:00 am ET
TMX Group Equity Financing Statistics - August 2019
Toronto Stock Exchange, TSX Venture Exchange
Sep 09, 2019 06:00 am ET
Organigram Receives Health Canada Approval to Bring Total Licensed Production Capacity to Target of 76,000 kg/yr1
Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (the “Company” or “Organigram”), a leading licensed producer of cannabis, is pleased to announce that effective September 6, 2019 it has received Health Canada’s approval for the licensing of 17 additional cultivation rooms under the Cannabis Regulations.
Aug 20, 2019 06:00 am ET
Organigram Announces Trading Date for Graduation to TSX
Organigram Holdings Inc. (NASDAQ: OGI) (TSX VENTURE: OGI), the parent company of Organigram Inc. (the “Company” or “Organigram”), a leading licensed producer of cannabis, is pleased to announce that it has received final approval for the listing of its common shares on the Toronto Stock Exchange (“TSX”).
Aug 08, 2019 08:00 pm ET
Organigram Conditionally Approved to Graduate to the TSX
Organigram Holdings Inc. (NASDAQ: OGI) (TSX VENTURE: OGI), the parent company of Organigram Inc. (the “Company” or “Organigram”), a leading licensed producer of cannabis, is pleased to announce it has received conditional approval from the Toronto Stock Exchange (“TSX”) to graduate from the TSX Venture Exchange (“TSXV”) and list its common shares on the TSX under the symbol “OGI.”
Jul 26, 2019 08:15 am ET
Organigram Signs New Agreement for Access to 60,000kg of CBD-rich Hemp
Organigram Holdings Inc. (NASDAQ Global Select; TSX-V: OGI) the parent company of Organigram Inc. (collectively the “Company” or “Organigram”), a leading licensed producer of cannabis, is pleased to announce that it has entered into an advance payment and purchase agreement (the “Payment Agreement”) with 703454 N.B. Inc. (carrying on business as 1812 Hemp) (“1812 Hemp”) under which the Company will pre-fund hemp purchases to receive access to as much as 60,000 kilograms of dried hemp flower to be harvested in calendar 2019 for extraction into cannabidiol (“CBD”) isolate.
Jul 15, 2019 06:00 am ET
Organigram Reports Third Quarter Fiscal 2019 Results
Organigram Holdings Inc. (NASDAQ: OGI) (TSX VENTURE: OGI), the parent company of Organigram Inc. (the “Company” or “Organigram”), a leading licensed producer of cannabis, is pleased to announce its results for the third quarter ended May 31, 2019 (“Q3” or “Q3 2019”).
Jul 10, 2019 06:01 am ET
Organigram and Lift & Co. Enhance Education of Cannabis Frontline Staff via Brand-Specific Training Program
Organigram Holdings Inc. (NASDAQ: OGI) (TSX VENTURE: OGI), the parent company of Organigram Inc. (the “Company” or “Organigram”), a leading licensed producer of cannabis, is pleased to announce a collaboration with Lift & Co. Corp ("Lift & Co.") (TSXV: LIFT) (OTCQB: LFCOF) to support the launch of Canada’s first branded cannabis educational program via Lift & Co.’s CannSell retail training program.
Jul 08, 2019 04:00 pm ET
Organigram Announces Expanded Development of Rapid-Onset Nano-Emulsification Technology for Cannabis Beverages
In anticipation of the legalization of adult use recreational cannabis edibles in Canada, as well as consumer demand for cannabis-infused beverages, Organigram Holdings Inc. (TSX VENTURE: OGI) (NASDAQ: OGI), the parent company of Organigram Inc. (the “Company” or “Organigram”), a leading licensed producer of cannabis, has developed a proprietary nano-emulsification technology that will allow for the production of both liquid and powdered cannabinoid products.
Jul 02, 2019 06:00 am ET
Organigram Holdings Inc. to Report Third Quarter Fiscal 2019 Results on July 15, 2019
MONCTON, NB, July 2, 2019 /CNW/ - Organigram Holdings Inc. (NASDAQ: OGI) (TSXV: OGI), the parent company of Organigram Inc. (the "Company" or "Organigram"), a leading licensed producer of cannabis, announced today it will report its third quarter earnings results for its fiscal year ended August 31, 2019 on Monday, July 15, 2019 before market open.  
Jul 02, 2019 06:00 am ET
Organigram Holdings Inc. to Report Third Quarter Fiscal 2019 Results on July 15, 2019
MONCTON, NB, July 2, 2019 /PRNewswire/ - Organigram Holdings Inc. (NASDAQ: OGI) (TSXV: OGI), the parent company of Organigram Inc. (the "Company" or "Organigram"), a leading licensed producer of cannabis, announced today it will report its third quarter earnings results for its fiscal year ended August 31, 2019 on Monday, July 15, 2019 before market open.  
Jun 24, 2019 06:00 am ET
Organigram Receives Health Canada Approval for an Additional 17 Cultivation Rooms in Phase 4A
Additional licensed cultivation space brings annual target production capacity to 61,000 kg/yr1
Jun 20, 2019 06:00 am ET
Organigram sends first shipment to Quebec; Organigram products now available in all ten provinces
MONCTON, NB, June 20, 2019 /CNW/ - Organigram Holdings Inc. (TSXV: OGI) (NASDAQ: OGI), the parent company of Organigram Inc. (the "Company" or "Organigram"), a leading licensed producer of cannabis, is pleased to announce that it has now shipped its first cannabis products to the province of Quebec, following purchase orders placed with the Société québécoise du cannabis (SQDC) and following registration with the Autorité des Marchés Publics.
Jun 18, 2019 12:12 pm ET
IIROC Trading Halt - OGI.WT.A
VANCOUVER, June 18, 2019 /CNW/ - The following issues have been halted by IIROC:
Jun 18, 2019 06:00 am ET
Organigram becomes exclusive Canadian supplier of Feather Company's design-patented vaporizer hardware and technology
Agreement pairs innovative Edison brand with unique, proprietary delivery mechanism for discerning & sophisticated consumers
Jun 07, 2019 09:15 am ET
Organigram Secures Partnership with PAX as Brand Partner
Partnership with PAX builds on Organigram's commitment to both quality and a strong leadership position with next generation cannabis products Organigram plans to offer Edison Cannabis Co. brand PAX Era pods coast to coast, through the Company's distribution arrangements in all of Canada's ten provinces Estimates suggest vape pens currently represent the largest segment of edibles and derivative based products at approximately 23 per cent of U.S. sales based on form factori
May 31, 2019 03:05 pm ET
Organigram Closes $140 Million Credit Facility with Bank of Montreal
Non-dilutive Financing Provides Company with Significant Financial Flexibility
May 31, 2019 06:00 am ET
Organigram Receives Organic Certification for Recreational Cannabis
MONCTON, NB, May 31, 2019 /CNW/ – Organigram Holdings Inc. (TSXV: OGI) (NASDAQ: OGI), the parent company of Organigram Inc. (the "Company" or "Organigram"), a leading licensed producer of cannabis, is pleased to announce its recreational cannabis plants and growing processes have been certified organic with Pro-Cert Organic Systems Ltd. ("Pro-Cert").
May 29, 2019 06:00 am ET
Organigram fulfills gap in Canadian CBD Market with Edison CBD Oil
Company sends initial shipments of more than 130 thousand units
May 20, 2019 06:00 am ET
Organigram to invest $15 million in industry-leading infused chocolate innovation
Company positioning itself to compete within expected largest cannabis edibles segment
May 17, 2019 08:35 am ET
Cannastocks2019 Investor Conference & Webinar Now Available for On-Demand Viewing
Individual and institutional investors as well as advisors are invited to log-on to VirtualInvestorConferences.com to view presentations
May 17, 2019 08:35 am ET
Cannastocks2019 Investor Conference & Webinar Now Available for On-Demand Viewing
NEW YORK, May 17, 2019 /PRNewswire/ -- Virtual Investor Conferences, in partnership with Midtown Partners & Co, LLC, today announced that the presentations from the Cannastocks2019 Q1 Virtual lnvestor Conference are available for on-demand viewing. The event featured presentations by public companies, providing insight on innovation, consolidation, international expansion and specialization in the fast-growing cannabis industry.
May 17, 2019 06:00 am ET
Organigram Announces May 21st as Inaugural Date of Trading on the Nasdaq Global Select Market
MONCTON, May 17, 2019 /CNW/ - Organigram Holdings Inc. (TSX VENTURE: OGI) (OTCQX: OGRMF), the parent company of Organigram Inc. (the "Company" or "Organigram"), a leading licensed producer of cannabis, is pleased to announce that its common shares will commence trading on the Nasdaq Global Select Market under the symbol "OGI" on Tuesday May 21, 2019. Organigram's common shares will continue to be listed and trade on the Toronto Venture Exchange (TSXV), also under the symbol "OGI". The Company's common shares will continue to trade on the OTCQX under the symbol "OGRMF" until market close on M
May 14, 2019 10:54 am ET
Cannastocks2019 Live-Stream Investor Conference & Webinar May 15th
Public Cannabis Company Executives share vision, answer questions live at VirtualInvestorConferences.com
May 14, 2019 08:35 am ET
Cannastocks2019 Live-Stream Investor Conference & Webinar May 15th
NEW YORK, May 14, 2019 /PRNewswire/ -- Virtual Investor Conferences, in partnership with Midtown Partners & Co, LLC, today announced the agenda for the upcoming Cannastocks2019 Q1 Virtual lnvestor Conference. Individual investors, institutional investors, advisors, and analysts are invited to listen and watch live. The event will feature presentations by public companies, providing insight on innovation, consolidation, international expansion and specialization in the fast-growing cannabis industry. The program opens at 9:00 AM ET on Wednesday, May 15th.
May 13, 2019 06:00 am ET
Organigram Strengthens Leadership Team with Government Relations Expert
Cameron Bishop Appointed Vice President, Public Affairs and Stakeholder Relations
Apr 30, 2019 06:00 am ET
Organigram Receives Perimeter License Amendment for Phases 4A and 4B as well as Initial 13 Cultivation Rooms in Phase 4A
Organigram meets schedule and is on track to increase target annualized production capacity to 113,000 kg1 by the end of 2019
Apr 26, 2019 06:30 pm ET
Organigram Announces Application to List on NASDAQ
MONCTON, NB, April 26, 2019 /CNW/ - Organigram Holdings Inc. (TSX VENTURE: OGI) (OTCQX: OGRMF), the parent company of Organigram Inc. (the "Company" or "Organigram"), a leading licensed producer of cannabis, announced today that it has applied to list its common shares on the NASDAQ Global Select Market ("NASDAQ").
Apr 15, 2019 06:00 am ET
Organigram Reports Second Quarter Fiscal 2019 Results; Record Net Revenue of $26.9 Million
Record net revenue of $26.9 million or more than double the net revenue of Q1-2019 Adjusted gross margin of $16.0 million or 60%1 Adjusted EBITDA of $13.3 million or adjusted EBITDA margin of 49%1 As planned, an amendment to our licence for Phase 4a and 4b of the Moncton facility was submitted to Health Canada in March for the security perimeter as well as the initial 13 grow rooms in Phase 4a The Phase 4 expansion is being completed in a series of stages which once fully licensed will bring our annualized production up to 113,000 kg by the end of 2019 Phase 5 refurbishment underway for an e
Apr 08, 2019 08:00 am ET
Organigram Holdings Inc. to Report Second Quarter Fiscal 2019 Results on April 15th, 2019
MONCTON, NB, April 8, 2019 /CNW/ - Organigram Holdings Inc. (TSX VENTURE: OGI) (OTCQX: OGRMF), the parent company of Organigram Inc. (the "Company" or "Organigram"), a leading licensed producer of cannabis, announced today it will report its second quarter results for its fiscal year ended August 31, 2019 on Monday, April 15, 2019 before market open.
Apr 07, 2019 06:00 pm ET
Organigram Appoints Chief of Staff and Announces Other Management Changes
MONCTON, NB, April 7, 2019 /CNW/ – Organigram Holdings Inc. (TSX VENTURE: OGI) (OTCQX: OGRMF), the parent company of Organigram Inc. (the "Company" or "Organigram"), a leading licensed producer of cannabis is pleased to announce the recent appointment of strategy and operations consultant James Cavanagh as the Company's Chief of Staff.
Apr 04, 2019 08:00 am ET
Canada Prepares for 420: Canadian Cannabis Companies Establishing an Online Presence
Investorideas.com, a leading investor news resource covering hemp and cannabis stocks concludes our two part series looking at the Canadian cannabis landscape and the numerous companies ensuring not only a brick and mortar footprint, but also...
Apr 03, 2019 08:00 am ET
Organigram announces resignation of Dr. Kenneth Mitton from Board of Directors
MONCTON, NB, April 3, 2019 /CNW/ - Organigram Holdings Inc. (TSX VENTURE: OGI) (OTCQX: OGRMF), the parent company of Organigram Inc. (the "Company" or "Organigram"), a leading licensed producer of cannabis announces the resignation of Dr. Kenneth Mitton from the Company's Board of Directors.
Apr 03, 2019 08:00 am ET
Organigram Releases Cross-Platform Mobile Application for Medical Patients
Allows registered patients to order products, manage profiles and connect with Company iOS and Android functionality Available for direct download at organigram.ca/app MONCTON, NB, April 3, 2019 /CNW/ - Organigram Holdings Inc. (TSX VENTURE: OGI) (OTCQX: OGRMF), the parent company of Organigram Inc. (the "Company" or "Organigram"), a leading licensed producer of cannabis is pleased to announce the release of a cross-platform patient-focused mobile application (the "Organigram Mobile App" or the "Application").
Mar 27, 2019 08:03 pm ET
Organigram Provides Update on Debenture Conversion
MONCTON, NB, March 27, 2019 /CNW/ - Organigram Holdings Inc. (the "Company") (TSX VENTURE: OGI) (OTCQX: OGRMF), today provided an update on its previously announced mandatory conversion (the "Conversion") of the Company's 6.0% convertible unsecured debentures due January 31, 2020 (the "Debentures") (OGI.DB).
Mar 18, 2019 03:11 pm ET
Organigram Announces Share Issuance
MONCTON, NB, March 18, 2019 /CNW/ - Organigram Holdings Inc. (TSX VENTURE: OGI) (OTCQX: OGRMF), the parent company of Organigram Inc. (together, the "Company" or "Organigram"), a leading licensed producer of cannabis announced that subject to the approval of the TSX Venture Exchange (the "TSXV"), the Company will issue 41,000 Common Shares (the "Shares") in the capital of Organigram to 9250-5999 Québec Inc. (the "Consultant") pursuant to an Advisory Services Agreement whereby the Consultant provided consulting and advisory services in respect to the cultivation of cannabis and related matter
Mar 12, 2019 08:00 am ET
Cannabis Stocks That Could See Significant Growth in Retail
Cannabis sales have been soaring since legalization in Canada but there's a lot more to come as the industry continues to change. With more retailers opening for business and the edibles market likely coming online this year, there's going to be...
Mar 04, 2019 05:23 pm ET
Organigram Provides Corporate Updates
MONCTON, NB, March 4, 2019 /CNW/ - Organigram Holdings Inc. (TSX VENTURE: OGI) (OTCQX: OGRMF), the parent company of Organigram Inc. (together, the "Company" or "Organigram"), a leading licensed producer of cannabis is pleased to provide the following corporate updates.
Feb 27, 2019 05:00 am ET
Organigram Announces Conversion of $98 Million Debentures Into Common Shares
MONCTON, NB, Feb. 27, 2019 /CNW/ - Organigram Holdings Inc. (TSX VENTURE: OGI) (OTCQX: OGRMF), announced today that the Company has elected to exercise its right under the indenture (the "Indenture") governing the Company's 6.0% convertible unsecured debentures due January 31, 2020 (the "Debentures") to convert (the "Conversion") all of the principal amount outstanding of the remaining Debentures on April 1, 2019 (the "Conversion Date") into common shares of the Company (the "Common Shares").
Feb 27, 2019 05:00 am ET
Organigram Announces Conversion of $98 Million Debentures Into Common Shares
MONCTON, NB, Feb. 27, 2019 /PRNewswire/ - Organigram Holdings Inc. (TSX VENTURE: OGI) (OTCQX: OGRMF), announced today that the Company has elected to exercise its right under the indenture (the "Indenture") governing the Company's 6.0% convertible unsecured debentures due January 31, 2020 (the "Debentures") to convert (the "Conversion") all of the principal amount outstanding of the remaining Debentures on April 1, 2019 (the "Conversion Date") into common shares of the Company (the "Common Shares").
Feb 26, 2019 05:00 am ET
Organigram Signs Quebec Letter of Intent; Now in All 10 Canadian Provinces
Supply agreement cements Organigram's position as a national leader in Canada's recreational cannabis marketplace
Feb 26, 2019 05:00 am ET
Organigram Signs Quebec Letter of Intent; Now in All 10 Canadian Provinces
Supply agreement cements Organigram's position as a national leader in Canada's recreational cannabis marketplace
Feb 20, 2019 05:00 am ET
Organigram ranked as 4th best performing stock on the OTCQX® Best Market for 2018
MONCTON, NB, Feb. 20, 2019 /CNW/ - Organigram Holdings Inc. (TSX VENTURE: OGI) (OTCQX: OGRMF), the parent company of Organigram Inc. (the "Company" or "Organigram"), a leading licensed producer of cannabis has been recognized as one of the 2019 OTCQX Best 50. Organigram was ranked as 4th best performing stock on the OTCQX® Best Market for 2018.
Feb 20, 2019 05:00 am ET
Organigram ranked as 4th best performing stock on the OTCQX® Best Market for 2018
MONCTON, NB, Feb. 20, 2019 /PRNewswire/ - Organigram Holdings Inc. (TSX VENTURE: OGI) (OTCQX: OGRMF), the parent company of Organigram Inc. (the "Company" or "Organigram"), a leading licensed producer of cannabis has been recognized as one of the 2019 OTCQX Best 50. Organigram was ranked as 4th best performing stock on the OTCQX® Best Market for 2018.
Feb 19, 2019 05:00 am ET
Organigram Releases Unprecedented Virtual Reality Tour of Moncton Campus, Home of Edison Cannabis
The first immersive, educational Canadian cannabis facility tour of its kind All aspects of production highlighted and explored from propagation to packaging Showcases our unique, three-tiered indoor production facility Allows customers, patients and investors alike to experience high-quality cannabis cultivation from anywhere in the world Available as an Android or iOS app for download, or available online at www.organigram.ca/investors/virtual-tour MONCTON, NB, Feb. 19, 2019 /CNW/ - Organigram Holdings Inc. (TSX VENTURE: OGI) (OTCQX: OGRMF), the parent company of Organigram Inc. (the "Com
Feb 05, 2019 08:00 am ET
Cannabis Pushes Advancement in Agritech
Investorideas.com, a leading investor news resource covering hemp and cannabis stocks releases a snapshot focusing on the new agritech wave of innovation in the cannabis sector. Since the passage of the Farm Bill late last year, the development...
Jan 31, 2019 05:00 am ET
Organigram Hits One Million Pre-Rolls, Continues Moncton Campus Expansion
Pre-roll production milestone allows Organigram to establish a leading market presence Phase 4 facility expansion continues, will add 91 incremental grow rooms in stages before the end of calendar 2019 Additional grow rooms will more than triple target annual production capacity to 113,000 kg once complete Moncton Campus producing high-quality indoor-grown product at low cash cost of cultivation (non-IFRS measure) of $0.56 per gram
Jan 29, 2019 05:10 am ET
Organigram Signs Multi-Year Cannabis Extraction Agreement with Valens GroWorks Corp.
Partnership supports Organigram's large-scale extraction and production strategy
Jan 29, 2019 05:10 am ET
Organigram Signs Multi-Year Cannabis Extraction Agreement with Valens GroWorks Corp.
Partnership supports Organigram's large-scale extraction and production strategy
Jan 28, 2019 05:28 am ET
Organigram Reports Record Net Revenue of $12.4 Million Up 287% Sequentially Quarter-over-Quarter; Adjusted Gross Margin of 71%
Net revenue growth due to first shipments of adult-use recreational product during the period Consists of gross revenue of $14.4 million less excise taxes and returns of $2.0 million Adjusted Gross Margin (a non-IFRS measure)1 equal to $8.8 million up from $1.6 million in prior quarter Cash cost of cultivation (a non-IFRS measure)1 equal to $0.56/dried flower equivalent gram ($0.74 "all-in" including non-cash costs) down from $0.62 ($0.83 "all-in") in the prior quarter MONCTON, NB, Jan. 28, 2019 /CNW/ - Organigram Holdings Inc. (TSX VENTURE: OGI) (OTCQX: OGRMF), the parent company of Organi
Jan 28, 2019 05:28 am ET
Organigram Reports Record Net Revenue of $12.4 Million Up 287% Sequentially Quarter-over-Quarter; Adjusted Gross Margin of 71%
Net revenue growth due to first shipments of adult-use recreational product during the period Consists of gross revenue of $14.4 million less excise taxes and returns of $2.0 million Adjusted Gross Margin (a non-IFRS measure)1 equal to $8.8 million up from $1.6 million in prior quarter Cash cost of cultivation (a non-IFRS measure)1 equal to $0.56/dried flower equivalent gram ($0.74 "all-in" including non-cash costs) down from $0.62 ($0.83 "all-in") in the prior quarter MONCTON, NB, Jan. 28, 2019 /PRNewswire/ - Organigram Holdings Inc. (TSX VENTURE: OGI) (OTCQX: OGRMF), the parent company of
Jan 25, 2019 11:12 am ET
Organigram Appoints Amy Schwalm Vice President, Investor Relations
New Appointment Brings Senior Investor Relations Experience from Industry Leaders in Communications and Mining Sectors
Jan 25, 2019 11:12 am ET
Organigram Appoints Amy Schwalm Vice President, Investor Relations
New Appointment Brings Senior Investor Relations Experience from Industry Leaders in Communications and Mining Sectors
Jan 23, 2019 05:00 am ET
Organigram improves compassionate care access for patients through enhanced OrganiCare program
Ease of access initiative makes it easier to qualify, also decreases the burden of medicinal cost for qualified patients
Jan 21, 2019 05:35 am ET
Organigram locks up supply of hemp-derived CBD through long-term agreement with industrial hemp research company
Research to focus on increasing CBD production in hemp and cannabis, while reducing transformation costs
Jan 21, 2019 05:00 am ET
Class Action Certified To Proceed to Trial
MONCTON, NB, Jan. 21, 2019 /CNW/ - A class action was certified against Organigram Inc. (the "Company" or "Organigram") and its parent company Organigram Holdings Inc. (TSX VENTURE: OGI) (OTCQX: OGRMF), a leading licensed producer of cannabis in Canada, on Friday, January 18, 2019.
Jan 16, 2019 05:00 am ET
Organigram continues to chart course to launch of cannabis edibles, partners with Canada's Smartest Kitchen to develop premium chocolate products
MONCTON, NB, Jan. 16, 2019 /CNW/ - Organigram Holdings Inc. (TSX VENTURE: OGI) (OTCQX: OGRMF), the parent company of Organigram Inc. (the "Company" or "Organigram"), a leading licensed producer of cannabis has partnered with Canada's Smartest Kitchen (CSK), a leader in food product development, to expand the Company's ongoing research and development related to edible cannabis products. Following the legalization of adult use recreational cannabis in Canada in 2018, cannabis edibles are expected to be legalized later in 2019 with the draft amendments to The Cannabis Act for edibles having be
Jan 15, 2019 05:00 am ET
Organigram makes Edison Cannabis the first legal brand to provide humidity control units in flower products ranging from 1g to 15g
Company's commitment to quality and consumer experience includes humidity control provided by Integra Boost technology
Jan 08, 2019 08:00 am ET
Investing in a New Age of Cannabinoid Production for Cost Efficiency and Scalability
Investorideas.com, a leading investor news resource covering hemp and cannabis stocks releases a snapshot of companies investing in new methods of cannabinoid production to meet the growing demands of the future According to Research and Markets,...
Dec 19, 2018 05:00 am ET
Organigram Announces Results of 2018 Annual & Special Meeting
MONCTON, NB, Dec. 19, 2018 /CNW/ - Organigram Holdings Inc. (TSX VENTURE:OGI) (OTCQB:OGRMF) (the "Company" or "Organigram"), a leading licensed producer of cannabis based in Moncton, New Brunswick, announces the results of its 2018 Annual and Special Meeting of Shareholders (the "Meeting") adjourned from Friday December 7, 2018 and reconvened on Monday, December 17, 2018 in Toronto.
Dec 14, 2018 05:00 am ET
Organigram reports impressive growth for 2018 in advance of adult recreational sales results
Results to August 31, 2018 showcase a Canadian leader in low-cost cultivation while growing high-quality indoor product
Dec 14, 2018 05:00 am ET
Organigram reports impressive growth for 2018 in advance of adult recreational sales results
Results to August 31, 2018 showcase a Canadian leader in low-cost cultivation while growing high-quality indoor product
Dec 07, 2018 09:38 am ET
Organigram Annual & Special Meeting Adjourned until December 17
MONCTON, Dec. 7, 2018 /CNW/ - Organigram Holdings Inc. (TSX VENTURE: OGI) (OTCQX: OGRMF), the parent company of Organigram Inc. (the "Company" or "Organigram"), a leading licensed producer of cannabis, announces that the Company's Annual and Special Meeting held earlier today has been adjourned and will be reconvened on December 17, 2018 at 10:00 a.m. (Toronto Time).  No business other than the adjournment was conducted at the Meeting.  The Meeting has been adjourned to allow for the Company's audited annual financial statements for the period ended August 31, 2018 to be presented to shareho
Dec 07, 2018 05:10 am ET
Nov 30, 2018 05:00 am ET
Organigram recognized by Best in Biz Awards 2018
Company wins silver in Company of the Year - East Canada category and provides update on timing for release of 2018 year-end results
Nov 27, 2018 05:00 am ET
Organigram becomes an official supplier of cannabis in the Province of Saskatchewan
Company also continues to expand senior management team
Nov 20, 2018 01:54 pm ET
Organigram Announces Board Nominees
Company announces new Board nominees, date of Shareholder Meeting and expected filing date for Annual Financials as it prepares for implementation of strategic objectives
Nov 13, 2018 01:34 pm ET
Université de Moncton partners with the Government of Canada, Genome Atlantic, Genome Canada, New Brunswick Innovation Foundation, and Organigram to advance cannabis research and increase productivity
Research to support growth of the cannabis industry in Atlantic Canada through the application and adaptation of novel biotechnologies
Oct 26, 2018 06:00 am ET
Organigram to supply cannabis coast to coast
Company signs supply agreement with Province of British Columbia
Oct 24, 2018 07:05 am ET
Organigram celebrates successful first week of legalization, applauds regional partners' success managing exceptional consumer demand
MONCTON. NB, Oct. 24, 2018 /CNW/ - Adult use recreational cannabis is now legal in Canada and Organigram Holdings Inc. (TSX VENTURE: OGI) (OTCQX: OGRMF), the parent company of Organigram Inc. (the "Company" or "Organigram"), a leading licensed producer of cannabis, is proud to be part of this historic moment in Canadian history. The company is also pleased to have collaborated with provinces and other jurisdictional partners across the country, supporting the successful launch of this new market.
Oct 17, 2018 07:51 am ET
Organigram Announces Definitive Agreement to Acquire 25% of alpha-cannabis® Pharma GmbH
Presence in Germany extends company's commitment to international expansion.
Oct 17, 2018 07:00 am ET
Organigram Closes Sale of Trauma Healing Centres to Harvest Medicine
Transaction liquidates non-strategic asset to one of Organigram's most trusted clinic partners
Oct 10, 2018 03:01 pm ET
IIROC Trading Resumption - OGI; OGI.DB; OGI.WT
VANCOUVER, Oct. 10, 2018 /CNW/ - Trading resumes in:
Oct 10, 2018 02:35 pm ET
Organigram Finalizes Certification Process with Ecocert Canada
Medical patients will be prioritizedas part of production plans for organic cannabis
Oct 10, 2018 01:44 pm ET
IIROC Trading Halt - OGI; OGI.DB; OGI.WT
VANCOUVER, Oct. 10, 2018 /CNW/ - The following issues have been halted by IIROC:
Oct 03, 2018 12:03 am ET
Early Warning Report Filed Pursuant to National Instrument 62-103
MONCTON, NB, Oct. 2, 2018 /CNW/ - Organigram Holdings Inc. (TSX VENTURE: OGI) (OTCQX: OGRMF): This press release is being disseminated as required by National Instrument 62-103 The Early Warning System and Related Take Over Bids and Insider Reporting Issues in connection with the acquisition of securities of Eviana Health Corporation ("Eviana" or the "Company") (CSE: EHC) (OTC:EVNNF) by Organigram Holdings Inc. (the "Acquiror") 
Oct 02, 2018 06:00 am ET
Organigram closes $5 Million investment in European hemp and CBD producer Eviana
MONCTON, NB, Oct. 2, 2018 /CNW/ - Organigram Holdings Inc. (TSX VENTURE: OGI) (OTCQX: OGRMF), the parent company of Organigram Inc. (the "Company" or "Organigram"), a leading licensed producer of medical marijuana, is pleased to announce that is has closed the previously-announced private placement investment in Eviana Health Corporation ("Eviana" or the "Issuer").
Sep 26, 2018 06:00 am ET
Trailblazer becomes newest addition to Organigram suite of adult recreational cannabis brands
Brand developed in response to priorities and requests for quality value products from retail partners across the country
Sep 20, 2018 01:35 pm ET
Investor Ideas Potcast, Cannabis News and Stocks on the Move: Canopy Growth Corporation, Canopy Rivers Inc. (TSXV: RIV), Organigram Holdings, CannaRoyalty and Beleave Inc.
Investor Ideas (https://www.investorideas.com), a global news source covering leading sectors including marijuana and hemp stocks and its potcast site, www.potcasts.ca releases today’s edition of its series, Investorideas.com potcastsCM; cannabis...
Sep 20, 2018 07:00 am ET
Organigram & Canopy Growth partner in Newfoundland and Labrador by signing supply agreement including distribution and retail services
Deal secures Organigram's portfolio within Canopy Growth's retail stores & launches B2B sales platform
Sep 14, 2018 11:03 am ET
Organigram signs supply agreement with Newfoundland and Labrador Liquor Corporation
MONCTON, NB, Sept. 14, 2018 CNW/ - Organigram Holdings Inc. (TSX VENTURE: OGI) (OTCQX: OGRMF), the parent company of Organigram Inc. (the "Company" or "Organigram"), a leading licensed producer of medical marijuana, is pleased to announce that the Company has signed a supply agreement with the Newfoundland and Labrador Liquor Corporation (NLC) in anticipation of the launch of a legal, adult use recreational cannabis market in the province.
Sep 14, 2018 06:00 am ET
Organigram Update on Proposed Investment in European CBD Hemp Producer Eviana
Organigram and Strategic Investor to Collectively Participate in $10 Million Private Placement Debenture into Eviana Health Corporation
Sep 13, 2018 03:44 pm ET
Global Cannabis Partnership Welcomes New Members
New Members will collaborate and contribute to development of Responsible Cannabis Framework
Sep 13, 2018 03:44 pm ET
Global Cannabis Partnership Welcomes New Members
New Members will collaborate and contribute to development of Responsible Cannabis Framework
Sep 13, 2018 06:00 am ET
Organigram invests in Hyasynth Biologicals Inc., helps bring transformative "cellular agriculture" to Canadian cannabis industry
Investment solidifies Organigram's commitment to next generation delivery of cannabinoid products to global medical and adult recreational cannabis markets
Sep 12, 2018 06:00 am ET
Sep 06, 2018 07:00 am ET
OTC Markets Group Welcomes Organigram Holdings, Inc. to OTCQX
NEW YORK, Sept. 6, 2018 /PRNewswire/ -- OTC Markets Group Inc. (OTCQX: OTCM), operator of financial markets for 10,000 U.S. and global securities, today announced Organigram Holdings, Inc. (TSX-V: OGI; OTCQX: OGRMF), company whose wholly-owned subsidiary, Organigram Inc., is a licensed producer of medical marijuana in Canada, has qualified to trade on the OTCQX® Best Market.  Organigram Holdings upgraded to OTCQX from the OTCQB® Venture Market.
Sep 06, 2018 06:00 am ET
Organigram Announces Trading on the OTCQX® Best Market
MONCTON, NB, Sept. 6, 2018 /CNW/ - Organigram Holdings Inc. (TSX VENTURE:OGI) (OTCQX:OGRMF), the parent company of Organigram Inc. (the "Company" or "Organigram"), a leading licensed producer of medical marijuana, today announced that it has qualified to trade on the OTCQX® Best Market.
Aug 31, 2018 02:18 pm ET
Organigram Announces the Issuance of RSU Awards
MONCTON, NB, Aug. 31, 2018 /CNW/ - Organigram Holdings Inc. (TSX VENTURE:OGI) (OTCQB:OGRMF), the parent company of Organigram Inc. (the "Company" or "Organigram"), a leading licensed producer of medical marijuana, today announced the grant of restricted share units ("RSUs") to certain officers, directors and employees of the Company.
Aug 27, 2018 09:00 am ET
Canadian parents concerned about legalization of cannabis, agree not enough information available to youth about cannabis use risks
MONCTON, NB, Aug. 27, 2018 /CNW/ - According to a survey commissioned by Organigram Inc., a leading licensed producer of medical marijuana (Parent company: Organigram Holdings Inc. (TSXV: OGI) (OTCQB: OGRMF)), a majority of Canadian parents (60 per cent) are concerned about cannabis legalization. More than half of the parents surveyed (54 per cent) feel there is currently not enough information available to youth about the risks associated with cannabis use and only three in ten parents feel "very prepared" to educate their children about cannabis.
Aug 24, 2018 09:35 am ET
Organigram signs supply agreement with Nova Scotia Liquor Corporation
Agreement is Company's sixth provincial supply arrangement, continues to build Company's national presence
Aug 01, 2018 12:46 pm ET
Mount Allison receives support from Organigram Inc. and NB Regional Development Corporation to support cannabis harms reduction education programming and initiatives
MONCTON, NB, Aug. 1, 2018 /CNW/ - Organigram Holdings Inc. (TSX VENTURE:OGI) (OTCQB:OGRMF), the parent company of Organigram Inc., a leading  licensed producer of medical marijuana and the New Brunswick Regional Development Corporation (RDC) will provide funding to Mount Allison to support the University's efforts to ensure the new legislation is fully communicated on campus, and to implement appropriate harms reduction initiatives established by the University.
Jul 30, 2018 06:00 am ET
Organigram Announces Record Q3 Financial Results - Net Income of $2.8 Million for the Quarter
Growth in production, dried flower sales, oil sales, inventory and the announcement of numerous sales agreements positions Organigram for successful launch of adult recreational use market
Jul 23, 2018 06:00 am ET
Organigram Provides Expansion Update as Phase 4 Construction Begins
Fully completed Phase 1, 2 and 3 cultivation facilities at Moncton campus bring target dried flower equivalent production to 36,000 kg/annum
Jul 10, 2018 06:00 am ET
Organigram Signs Strategic Supplier Agreement with Hiku Brands
Agreement brings up to 1,000kg of Organigram's premium indoor-grown cannabis products to Tokyo Smoke, Hiku's licensed chain of cannabis stores in Manitoba
Jul 05, 2018 07:20 am ET
Organigram signs supply agreement with the Alberta Gaming, Liquor & Cannabis Commission (AGLC)
With approved supplier status in Alberta, Organigram continues to expand national footprint 
Jun 29, 2018 06:00 am ET
Organigram signs supply agreement with Manitoba Liquor & Lotteries
MONCTON, NB, June 29, 2018 /CNW/ - Organigram Holdings Inc. (TSX VENTURE: OGI) (OTCQB: OGRMF), the parent company of Organigram Inc. (the "Company" or "Organigram"), a leading licensed producer of medical marijuana based in Moncton, New Brunswick, is pleased to announce that it has been approved as a supplier of cannabis for the province of Manitoba.
Jun 08, 2018 11:30 am ET
Orgranigram applauds Senate vote in support of Bill C-45
MONCTON, NB, June 8, 2018 /CNW/ - Organigram Holdings Inc. (TSX VENTURE:OGI) (OTCQB:OGRMF) (the "Company" or "Organigram"), a leading licensed producer of medical marijuana based in Moncton, New Brunswick, is pleased that Bill C-45 has been passed by the Senate in a historic vote, clearing another key milestone on the way to the legalization of adult-use recreational cannabis in Canada.
Jun 05, 2018 06:00 am ET
Organigram Announces Health Canada Licensing of Phase 3 Cultivation Expansion
Licensed production capacity expected to be 36,000 kg/yr by end of June 2018
Jun 04, 2018 08:25 am ET
Organigram Enters into Non-Binding Term Sheet for 26% Equity Interest in Eviana Health Corporation
Toronto, Ontario (FSCwire) - Organigram Holdings Inc. (“Organigram”) (TSX VENTURE: OGI) (OTCQB: OGRMF) and Eviana Health Corporation (“Eviana”) (CSE: EHC) (OTC: EVNNF) (collectively the “Companies”) are pleased to jointly announce that the Companies have entered into a non-binding term sheet (the “Term Sheet”) whereby Organigram will make a significant equity investment into Eviana.  Additionally, the Term Sheet contemplates Organigram entering into an offtake agreement with Eviana for up to 50% of the cannabidiol (“CBD”) production of Eviana for a period of five years, subject to adjustment based on Organigram’s equity interest in Eviana.
May 24, 2018 06:00 am ET
Organigram Announces Letter of Intent for Strategic Investment in Hyasynth Biologicals Inc.
Investment in Hyasynth Biologicals Inc. would advance Organigram's interest in next generation cannabinoids
May 17, 2018 06:00 am ET
Organigram Receives Permit to Export Medical Cannabis to Australia
Company Continues to Build International Presence Leveraging Award-Winning, High-Quality Product
May 15, 2018 06:00 am ET
Organigram Announces Receipt of License for Controlled Drugs and Substances from Health Canada
"Dealer's License" will permit greater research and development opportunities for new products and formulations
May 15, 2018 06:00 am ET
Organigram Unveils Comprehensive Suite of Adult Recreational Cannabis Brands
Consumer preferences, authenticity and segmentation at heart of industry-leading brand portfolio
May 08, 2018 06:00 am ET
Organigram Announces First International Expansion Investment
Potential investment in alpha-cannabis® Pharma GmbH represents strategic opportunity to deliver product to the German market